Search bioRxiv⌕ Search

Biology subjects

Klee, A.

Publications and source records attributed to Klee, A..

2 recordsLinked to original sources

Loss of PRDM16 Drives Nasal Septal Deviation through Dysregulated TGFβ2 Signaling

Nasal septal deviation affects approximiately 20% of newborns globally and 80% individuals in the United States. GWAS have linked PRDM16, a histone methyltransferase, to craniofacial abnormalities, yet its role in nasal septum development remains poorly understood. Global Prdm16 knockout mice (Prdm16-/-) exhibit severe craniofacial defects resembling Pierre Robin Syndrome but are neonatally lethal, precluding their potential applications for postnatal study. To address this, we generated an osteochondral lineage-specific, Prdm16 conditional knockout (Col2a1-Cre; Prdm16flox/flox; cKO) mouse model. Both sexes of cKO mice display significantly shorter nasal bone length, with a sex-dependent increase in nasal bone volume fraction of 12 wk old males. Nasal septal deviation is detectable as early as postnatal day 15 and progresses with age. Single-cell RNA sequencing (scRNA-seq) of 4 wk old nasal septal cartilage revealed a marked shift in chondrocyte composition: Mgp+ chondrocytes were substantially reduced, while Col10a1+/Serpina3n+hypertrophic chondrocytes were dramatically increased, indicating PRDM16 regulates chondrocyte phenotypes. Spatial transcriptomics localized Mgp+ chondrocytes and Col1a1high/Col3a1+fibrotic cells to the septal cartilage-bone interface (the site of deviation in cKO mice). Intercellular communication analyses revealed a switch in dominant sender cells from the fibrotic population in WT to Mgp+chondrocytes in cKO. MultiNicheNet bioinformatic analyses identified elevated TGF{beta}2 signaling at the nasal septal deviation site. Specifically, TGF{beta}2 secreted by Mgp+ chondrocytes was predicted to promote Col1a1/Col1a2 expression, resulting in fibrotic extracellular matrix (ECM) deposition and osteogenesis; consistent with elevated RUNX2 in cKO mice. TGF{beta}2 immunohistochemical staining confirmed increased TGF{beta}2 cells in the fibrous ECM and apical nasal cartilage of cKO, but not WT mice. Loss of PRDM16 also increased chondrocyte apoptosis at 4 and 12 wks of age. These findings demonstrate that loss of PRDM16 drives hypertrophic and fibrotic remodeling of nasal septal cartilage through dysregulation of TGF{beta}2 signaling, establishing a mechanistic basis for nasal septal deviation.

developmental biology↗

PRDM16 Coordinates Genetic and Epigenetic Programs Governing Chondrogenesis and Chondrocyte Phenotype Specification in the Knee Joint

Cartilage development and homeostasis require precise regulation by transcriptional and epigenetic networks. PRDM16 is a transcription factor containing zinc finger domains that enable protein-DNA and protein-protein interactions, as well as domains with the capacity for histone methyltransferase activity. However, the detailed molecular mechanisms by which PRDM16 regulates chondrogenesis and chondrocyte identities remain largely unknown. Using our osteochondral lineage-specific, conditional knockout mouse model (Col2a1Cre;Prdm16flox/flox, Prdm16 cKO), we found that loss of Prdm16 in osteochondral lineage cells delays, but does not fully inhibit, endochondral ossification and bone formation in the knee joint. Furthermore, Prdm16 cKO male mice exhibit comparable OA severity between injured and non-injured joints, suggesting that PRDM16 may exert a chondroprotective function. In our hiPSC-derived chondrocyte model, we observed significantly reduced pellet size and DNA content in cells with modulated PRDM16 expression compared to Control, implying a link between PRDM16 and chondrocyte viability. Integrated analysis of single cell RNA-sequencing and CUT&RUN-sequencing revealed that PRDM16 regulates chondrocyte cell fate decisions by altering chromatin accessibility and DNA binding at promoter/enhancer regions of genes essential for chondrogenesis and chondrocyte hypertrophy. Indeed, PRDM16 governs the expression of key chondrogenic regulators including SOX9, ARID5A, SMOC2, HAND2, and hypertrophic driver MEF2C. Overall, our results provide evidence that PRDM16 serves as an essential genetic and epigenetic regulator of chondrogenesis and chondrocyte phenotype specification in the knee joint through DNA binding and by modulating H3K4me3 histone mark deposition.

pathology↗